Altered JS-2 expression in colorectal cancers and its clinical pathological relevance
- Published in:
- Molecular Oncology, 2011, v. 5, n. 5, p. 475, doi. 10.1016/j.molonc.2011.06.003
- By:
- Publication type:
- Article
Works matching IS 15747891 AND DT 2011 AND VI 5 AND IP 5
Results: 9
1
2
Tumor suppressive activity of prolyl isomerase Pin1 in renal cell carcinoma
- Published in:
- Molecular Oncology, 2011, v. 5, n. 5, p. 465, doi. 10.1016/j.molonc.2011.06.002
- By:
- Publication type:
- Article
3
Frequent alterations of LOH11CR2A, PIG8 and CHEK1 genes at chromosomal 11q24.1-24.2 region in breast carcinoma: Clinical and prognostic implications
- Published in:
- Molecular Oncology, 2011, v. 5, n. 5, p. 454, doi. 10.1016/j.molonc.2011.06.005
- By:
- Publication type:
- Article
4
Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer
- Published in:
- Molecular Oncology, 2011, v. 5, n. 5, p. 438, doi. 10.1016/j.molonc.2011.07.003
- By:
- Publication type:
- Article
5
Mechanism of p27 upregulation induced by downregulation of cathepsin B and uPAR in glioma
- Published in:
- Molecular Oncology, 2011, v. 5, n. 5, p. 426, doi. 10.1016/j.molonc.2011.07.004
- By:
- Publication type:
- Article
6
Functional significance of the ATP-binding cassette transporter B6 in hepatocellular carcinoma
- Published in:
- Molecular Oncology, 2011, v. 5, n. 5, p. 410, doi. 10.1016/j.molonc.2011.07.005
- By:
- Publication type:
- Article
7
Increases in mitochondrial biogenesis impair carcinogenesis at multiple levels
- Published in:
- Molecular Oncology, 2011, v. 5, n. 5, p. 399, doi. 10.1016/j.molonc.2011.07.008
- By:
- Publication type:
- Article
8
On the Horizon: Europe’s next round of science funding
- Published in:
- Molecular Oncology, 2011, v. 5, n. 5, p. 395, doi. 10.1016/j.molonc.2011.09.001
- By:
- Publication type:
- Article
9
Editorial Board
- Published in:
- Molecular Oncology, 2011, v. 5, n. 5, p. ii, doi. 10.1016/S1574-7891(11)00105-0
- Publication type:
- Article